The IPKat

FEBRUARY 23, 2023

In that regard, punitive damages for IPRs infringements have found their places in, but not limited to, China’s Civil Code (CCC), Copyright Law, Trade Mark Law and Patent Law (see former IPKat posts here and here ). In April 2021, Jin sued Baijia store for patent infringement. One month later, a settlement was reached.

Settlement 70

Settlement Patent Infringement Patent Intellectual Property 70

LexBlog IP

FEBRUARY 7, 2023

This is the latest in the series titled “NPE Showcase,” where we discuss high-volume non-practicing entities (or as some call them, “patent trolls”). This installment will focus on a company named Sockeye Licensing TX, LLC. Settlement agreements are typically confidential so the exact arrangement is unclear.

Licensing 40

Licensing Settlement Patent Troll Confidentiality 40

JD Supra Law

JANUARY 11, 2024

After years of patent litigation, they entered into a settlement and license agreement. The agreement included mutual covenants not to challenge each other’s patents during a “Covenant Period.” But an exception allowed either company to challenge a patent asserted. By: Alston & Bird

Settlement 65

Settlement Patent Licensing Litigation 65

IP Law 360

NOVEMBER 22, 2023

Patent licensing company Arigna has agreed to drop its patent suit in the Western District of Texas against Apple, almost a year and a half after the Irish business reached a settlement with Samsung in the same court.

Settlement 52

Settlement Patent Licensing Business 52

Fish & Richardson Trademark & Copyright Thoughts

OCTOBER 5, 2022

Stec, from testifying as to reasonable royalty damages, where Dr. Stec had relied on a license agreement between third parties, jury verdicts, and settlement agreements. Rather, IOENGINE contended that “built-in apportionment” attributable to the licenses which Dr. Stec relied on satisfied the apportionment requirement.

Settlement 40

Settlement Licensing Litigation Technology 40

JD Supra Law

DECEMBER 1, 2021

The Federal Circuit has provided additional guidance about an appellant’s standing to appeal IPR decisions after settling the related litigations and entering into patent license agreements. In its second decision between the parties on this topic, the court has dismissed the appeal for lack of Article III standing in Apple Inc.

Licensing 52

Licensing Litigation Settlement Art 52

IP Law 360

NOVEMBER 10, 2021

district court data on how patent damages expert testimony has been challenged based on comparability, and how courts have ruled with regard to license and settlement agreements, litigation verdicts, market studies and more. Rich Franciosa and Michael Herrigel at Charles River Associates analyze nearly seven years of U.S.

Settlement 98

Settlement Patent Licensing Litigation 98

JD Supra Law

JANUARY 26, 2024

Jude Medical wanted to put its dispute with Niazi Licensing Corp. Jude Medical's too-quick response to a mediator's email left it stuck with a settlement it didn't want. In a patent case, there are always loose ends that remain before a settlement can be finalized. NLC) to bed. By: Axinn, Veltrop & Harkrider LLP

Settlement 65

Settlement Licensing Litigation Patent 65

IAM Magazine

DECEMBER 14, 2021

A preliminary injunction has been issued against the state’s strict reverse payment law, but antitrust considerations are here to stay in IP litigation settlements.

Settlement 52

Settlement Litigation IP Patent 52

Patent Trademark Blog

JUNE 5, 2023

Is patent enforcement possible for small companies? Whatever people may have heard about patent enforcement, one thing is clear. Almost everyone knows that patent infringement lawsuits are expensive. If patent infringement litigation is so costly, what options are available to startups and small businesses?

Patent Infringement 52

Patent Infringement Cease and Desist Patent Litigation 52

IP Law 360

DECEMBER 4, 2023

A Texas licensing company and Taiwanese manufacturer ASUSTeK Computer Inc. came to an 11th-hour settlement agreement over the weekend in a patent dispute that was scheduled to go to trial Monday.

Settlement 40

Settlement Patent Licensing 40

IPilogue

APRIL 22, 2022

Patent 8,129,385 (“patent 385”). This article delves into the legal doctrines that support the parties’ claims and the overarching strategy to their settlement. ViiV alleges Gilead infringed upon patent 385 under the doctrine of equivalents, which has two exclusions: dedication-disclosure and specific exclusion.

Patent 120

Patent Settlement Invention Inventor 120

IPilogue

AUGUST 24, 2022

NPEs are a special type of entity that specifically purchases patents or patent rights but does not commodify the patent. The second kind, private parties, often use the patents they acquire for profit through damage or settlement awards, or royalties and licensing rights.

Litigation 106

Litigation Patent Troll Patent Technology 106

IP Watchdog

JANUARY 3, 2024

entered into a settlement and license agreement in 2014, following years of patent litigation over their competing glucose monitoring system patents. Court of Appeals for the Federal Circuit (CAFC) today issued a precedential ruling that affirmed a district court’s denial of preliminary injunction to DexCom, Inc.,

Settlement 57

Settlement Contracts Government Licensing 57

IAM Magazine

DECEMBER 14, 2021

A preliminary injunction has been issued against the state’s strict reverse payment law, but antitrust considerations are here to stay in IP litigation settlements.

Settlement 40

Settlement Litigation IP Patent 40

Intepat

MAY 4, 2023

Interface of Competition Law and Patents Patent law particularly bears more relevance to antitrust jurisprudence. Patent law operates on two principles i.e. to encourage innovation and to promote the progress of science and technology. The problem arises when the push and pull of competition law and patent law cause friction.

Law 52

Law Patent Settlement Inventor 52

LexBlog IP

MARCH 6, 2024

On February 29, Biocon Biologics Ltd announced that it signed a settlement and license agreement with Janssen Biotech Inc. As part of the settlement, Biocon has agreed to terminate the pending inter partes review of Janssen and J&J’s U.S. Amgen secured a U.S.

Marketing 52

Marketing Marketing Settlement Licensing 52

IP Watchdog

NOVEMBER 26, 2021

A light week last week headed into the holidays saw 20 Patent Trial and Appeal Board filings (two more against MemoryWeb, and a lot of one-offs, including one by gaming company Zynga against IGT).

Settlement 62

Settlement Patent Licensing Government 62

IAM Magazine

JUNE 29, 2021

Deal ends litigation in China and Europe, with Xiaomi gaining rights to mobile patents owned by Sisvel and Mitsubishi Electric.

Settlement 52

Settlement Patent Litigation Licensing 52

IP Watchdog

JULY 14, 2023

This week in Other Barks & Bites: the U.S.

Licensing 52

Licensing Settlement Music Litigation 52

IAM Magazine

JANUARY 9, 2022

Get ready for the new working week with a summary of all the stories posted on the IAM platform over the past seven days.

Settlement 98

Settlement Licensing Patent Blogging 98

LexBlog IP

MARCH 15, 2024

at a future date “[i]n accordance with [Fresenius Kabi’s] patent settlement agreement with Genentech” under which Fresenius Kabi has a license to market its tocilizumab products in the U.S. starting at confidential license dates. TYENNE will be available in the U.S.

Confidentiality 52

Confidentiality Settlement Licensing Marketing 52

Patent Trademark Blog

JUNE 7, 2023

What makes the cost of patent litigation so high? What would you think if I told you that the average patent litigation cost exceeds well over $1 million ? To put it another way, how would you feel knowing that one million dollars might not get you halfway through a patent lawsuit? What factors make patent litigation so costly?

Litigation 52

Litigation Patent Patent Infringement Licensing 52

LexBlog IP

MARCH 15, 2023

But a jury in Utah found last week that Dish infringed the claims of two patents owned by ClearPlay and found damages in the amount of $469 million. That theory is ubiquitous in patent damages jurisprudence and looks to fifteen separate factors, none of them dispositive. So the question becomes—would DISH really have paid $42.6

Patent 52

Patent Technology Settlement Licensing 52

LexBlog IP

APRIL 13, 2023

VirnetX is a classic example of an NPE that does not qualify as a “patent troll.” Patent trolls leverage the litigation system to negotiate settlements for less than the cost of defending against a lawsuit. VirnetX, on the other hand, licenses its patents for eight and sometimes nine figures.

Patent Troll 52

Patent Troll Settlement Licensing Confidentiality 52

IP Law 360

JANUARY 18, 2022

German patent licensing company IPCom has announced that it reached a settlement with Taiwanese electronics maker HTC, closing the book on a patent dispute that began more than a decade ago and saw wrangling in courts around the world.

Settlement 40

Settlement Patent Licensing 40

JD Supra Law

DECEMBER 14, 2021

A number of small providers are receiving patent demand letters with a settlement or licensing offer to avoid litigation. Many of these letters are a typical part of the playbook of entities that have been variously called “non-practicing entities” (NPEs) or “patent trolls.” How should you respond? Should you respond?

Patent Troll 52

Patent Troll Settlement Litigation Patent 52

JD Supra Law

APRIL 14, 2023

VirnetX is a classic example of an NPE that does not qualify as a “patent troll.” Patent trolls leverage the litigation system to negotiate settlements for less than the cost of defending against a lawsuit. VirnetX, on the other hand, licenses its patents for eight and sometimes nine figures. How can you tell?

Patent Troll 52

Patent Troll Confidentiality Settlement Licensing 52

Bio Law Blog

JUNE 21, 2020

settled three Inter Partes Review (IPR) proceedings concerning patents covering Alexion’s blockbuster humanized monoclonal antibody drug Soliris®, with Amgen obtaining a royalty-free license for marketing a biosimilar prior to expiration of the patents at issue. The patents at issue are U.S. Patent Nos.

Marketing 52

Marketing Marketing Settlement Patent 52

IP Law 360

JANUARY 14, 2022

announced the settlement Friday of a multiyear patent dispute with MSN Pharmaceuticals and Impax Laboratories, based in part on a future licensing agreement with MSN and Impax covering Vanda's Hetlioz product, used for some types of sleep-wake disorders. Vanda Pharmaceuticals Inc.

Settlement 40

Settlement Patent Licensing 40

Patently-O

DECEMBER 11, 2022

Some background and how this Played out for Uniloc : HP sold several patents to Uniloc back in 2017 who then sued Apple, Motorola, and Blackboard for patent infringement. Uniloc has a litigation financing relationship with Fortress with the patents serving as collateral for the deal. After some venue-action, Uniloc v.

Licensing 130

Licensing Settlement Litigation Patent 130

IAM Magazine

NOVEMBER 5, 2021

An August litigation settlement with the Chinese giant means that 55% of the market is now taking licences from the firm.

Licensing 52

Licensing Settlement Marketing Marketing 52

JD Supra Law

MARCH 21, 2022

settlement agreement with Abbvie that grants Alvotech non-exclusive rights to market AVT02 (adalimumab) in the U.S AbbVie confirmed the resolution of disputes and stated that Alvotech will take a non-exclusive license to the patents, and in return, pay royalties and acknowledge the licensed patents’ validity.

Settlement 52

Settlement Licensing Marketing Marketing 52

Patently-O

OCTOBER 5, 2021

The USPTO is seeking comments on “the state of patent eligibility jurisprudence” and how eligibility law impacts both innovation and investment-in-innovation. and (2) Is patent eligibility a question of law for the court or a question of fact for the jury? The deadline for submissions is October 15, 2021. Berkheimer, No.

Patent 102

Patent Intellectual Property Invention Inventor 102

The IP Law Blog

JUNE 1, 2023

Kewalramani), the Central District of California denied Defendant Netflix’s attempts to compel Plaintiff GoTV Streaming to provide documents and further information as to the source of the litigation funding that GoTV received in conjunction with the patent litigation. D]efendant could not receive the information any other way.”

Litigation 96

Litigation Licensing Settlement Patent 96

IP Law 360

MAY 1, 2023

Circuit panel questioned an attorney for the Federal Trade Commission on Monday about what makes a 2017 settlement between Endo Pharmaceuticals and Impax over an opioid medication that the agency is challenging different from "garden variety" patent licensing agreements.

Settlement 40

Settlement Licensing Patent 40

The IPKat

JUNE 21, 2022

The analysis is complemented by a case study of the MPEG-2 patent pool, as well as by suggestions for further avenues in economic research of IP. Cristof Augenstein follows with Chapter 3, where he discusses patent enforcement in Europe. The book closes with Chapter 9, written by Rochelle Cooper Dreyfuss.

Intellectual Property 126

Intellectual Property Invention Social Media IP 126